CSPI targets juice capsules
This article was originally published in The Tan Sheet
FDA should halt the marketing of NSA's Juice Plus+ Orchard Blend and Juice Plus+ Garden Blend capsules because the products appear to be adulterated and misbranded, the Center for Science in the Public Interest says in a letter to the agency Dec. 12. CSPI says it is concerned the products' claim, "the next best thing to fruits and vegetables," may lead consumers to believe the pills are "closer to real fruits and vegetables than is likely to be the case." The labels say the capsules contain high levels of vitamins A and C and folate naturally, and do not disclose that these vitamins and minerals are added to the capsules during processing and are nutrients only characteristic of the original fruit and vegetable sources...
You may also be interested in...
Just five weeks before the US election, a Medtech Insight analysis shows medical device companies are spending more on Democrat Joe Biden’s campaign than on Republican Donald Trump’s.
Denmark’s Orphazyme has raised more funds to market its lead product, the heat shock protein amplifier, arimoclomol, in the US and Europe, and to evaluate the compound for other lysosomal storage and neurodegenerative disorders.
Pacific Biosciences of California and Aziyo Biologics both acquire new finance chiefs; Illumina hires a new chief marketing officer; WishBone Medical president moves over to take helm at Electromedical Products International; and more.